Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dharmalingam Subramaniam

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Current Pharmacology Reports|June 2, 2015
Manipulating miRNA Expression: A Novel Approach for Colon Cancer Prevention and ChemotherapySatish Ramalingam, Dharmalingam Subramaniam, Shrikant Anant
Immuno-Gastroenterology|June 25, 2013
Reduced Expression of RNA Binding Protein CELF2, a Putative Tumor Suppressor Gene in Colon CancerSatish Ramalingam, Prabhu Ramamoorthy, Dharmalingam Subramaniam, et al.
Current Medicinal Chemistry|February 1, 2017
Targeting Cancer Stem Cells for Chemoprevention of Pancreatic CancerDharmalingam Subramaniam, Gaurav Kaushik, Prasad Dandawate, et al.
Frontiers in Oncology|May 14, 2014
DNA methyltransferases: a novel target for prevention and therapyDharmalingam Subramaniam, Ravi Thombre, Animesh Dhar, et al.
Molecular Cancer Therapeutics|February 22, 2013
Tandutinib inhibits the Akt/mTOR signaling pathway to inhibit colon cancer growthSivapriya Ponnurangam, David Standing, Parthasarathy Rangarajan, et al.
Mini Reviews in Medicinal Chemistry|April 8, 2010
Cancer stem cells: a novel paradigm for cancer prevention and treatmentDharmalingam Subramaniam, Satish Ramalingam, Courtney W Houchen, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 16, 2012
Prevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptorCate Moriasi, Dharmalingam Subramaniam, Shanjana Awasthi, et al.
Current Colorectal Cancer Reports|December 6, 2013
Honokiol as a Radiosensitizing Agent for Colorectal cancersZhiyun He, Dharmalingam Subramaniam, Zhongtao Zhang, et al.
Chinese Journal of Natural Medicines|March 13, 2016
Bitter melon: a panacea for inflammation and cancerPrasad R Dandawate, Dharmalingam Subramaniam, Subhash B Padhye, et al.
Seminars in Cancer Biology|September 10, 2016
Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapyPrasad R Dandawate, Dharmalingam Subramaniam, Roy A Jensen, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Current Pharmacology Reports|June 2, 2015
Manipulating miRNA Expression: A Novel Approach for Colon Cancer Prevention and ChemotherapySatish Ramalingam, Dharmalingam Subramaniam, Shrikant Anant
Immuno-Gastroenterology|June 25, 2013
Reduced Expression of RNA Binding Protein CELF2, a Putative Tumor Suppressor Gene in Colon CancerSatish Ramalingam, Prabhu Ramamoorthy, Dharmalingam Subramaniam, et al.
Current Medicinal Chemistry|February 1, 2017
Targeting Cancer Stem Cells for Chemoprevention of Pancreatic CancerDharmalingam Subramaniam, Gaurav Kaushik, Prasad Dandawate, et al.
Frontiers in Oncology|May 14, 2014
DNA methyltransferases: a novel target for prevention and therapyDharmalingam Subramaniam, Ravi Thombre, Animesh Dhar, et al.
Molecular Cancer Therapeutics|February 22, 2013
Tandutinib inhibits the Akt/mTOR signaling pathway to inhibit colon cancer growthSivapriya Ponnurangam, David Standing, Parthasarathy Rangarajan, et al.
Mini Reviews in Medicinal Chemistry|April 8, 2010
Cancer stem cells: a novel paradigm for cancer prevention and treatmentDharmalingam Subramaniam, Satish Ramalingam, Courtney W Houchen, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 16, 2012
Prevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptorCate Moriasi, Dharmalingam Subramaniam, Shanjana Awasthi, et al.
Current Colorectal Cancer Reports|December 6, 2013
Honokiol as a Radiosensitizing Agent for Colorectal cancersZhiyun He, Dharmalingam Subramaniam, Zhongtao Zhang, et al.
Chinese Journal of Natural Medicines|March 13, 2016
Bitter melon: a panacea for inflammation and cancerPrasad R Dandawate, Dharmalingam Subramaniam, Subhash B Padhye, et al.
Seminars in Cancer Biology|September 10, 2016
Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapyPrasad R Dandawate, Dharmalingam Subramaniam, Roy A Jensen, et al.
Pageof 6